|
1
|
Neu SD and Dittel BN: Characterization of
definitive regulatory B cell subsets by cell surface phenotype,
function and context. Front Immunol. 12:7874642021. View Article : Google Scholar
|
|
2
|
Mohib K, Cherukuri A, Zhou Y, Ding Q,
Watkins SC and Rothstein DM: Antigen-dependent interactions between
regulatory B cells and T cells at the T:B border inhibit subsequent
T cell interactions with DCs. Am J Transplant. 20:52–63. 2020.
View Article : Google Scholar
|
|
3
|
Amu S, Saunders SP, Kronenberg M, Mangan
NE, Atzberger A and Fallon PG: Regulatory B cells prevent and
reverse allergic airway inflammation via FoxP3-positive T
regulatory cells in a murine model. J Allergy Clin Immunol.
125:1114–1124.e8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vomhof-DeKrey EE, Yates J, Hägglöf T,
Lanthier P, Amiel E, Veerapen N, Besra GS, Karlsson MC and
Leadbetter EA: Cognate interaction with iNKT cells expands
IL-10-producing B regulatory cells. Proc Natl Acad Sci USA.
112:12474–12479. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boldison J, Da Rosa LC, Davies J, Wen L
and Wong FS: Dendritic cells license regulatory B cells to produce
IL-10 and mediate suppression of antigen-specific CD8 T cells. Cell
Mol Immunol. 17:843–855. 2020. View Article : Google Scholar :
|
|
6
|
Geladaris A, Häusser-Kinzel S, Pretzsch R,
Nissimov N, Lehmann-Horn K, Häusler D and Weber MS: IL-10-providing
B cells govern pro-inflammatory activity of macrophages and
microglia in CNS autoimmunity. Acta Neuropathol. 145:461–477. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yanaba K, Bouaziz JD, Haas KM, Poe JC,
Fujimoto M and Tedder TF: A regulatory B cell subset with a unique
CD1dhiCD5+ phenotype controls T cell-dependent inflammatory
responses. Immunity. 28:639–650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosser EC and Mauri C: Regulatory B cells:
Origin, phenotype, and function. Immunity. 42:607–612. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shang J, Zha H and Sun Y: Phenotypes,
Functions, and Clinical Relevance of Regulatory B Cells in Cancer.
Front Immunol. 11:5826572020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong J, Fang J, Lan R, Tan Q, Tian Y,
Zhang M, Okunieff P, Zhang L, Lin J and Han D: TLR9 mediated
regulatory B10 cell amplification following sub-total body
irradiation: Implications in attenuating EAE. Mol Immunol.
83:52–61. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheremyan EA, Ustiugova AS, Karamushka NM,
Uvarova AN, Stasevich EM, Bogolyubova AV, Kuprash DV and Korneev
KV: Breg-Mediated Immunoregulation in the Skin. Int J Mol Sci.
25:5832024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mauri C and Menon M: Human regulatory B
cells in health and disease: therapeutic potential. J Clin Invest.
127:772–779. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu CR, Choi JK, Uche AN and Egwuagu CE:
Production of IL-35 by Bregs is mediated through binding of
BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements. J
Leukoc Biol. 104:1147–1157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oleinika K, Mauri C and Salama AD:
Effector and regulatory B cells in immune-mediated kidney disease.
Nat Rev Nephrol. 15:11–26. 2019. View Article : Google Scholar
|
|
15
|
Elias C, Chen C and Cherukuri A:
Regulatory B cells in solid organ transplantation: From immune
monitoring to immunotherapy. Transplantation. 108:1080–1089.
2024.
|
|
16
|
Juneja T, Kazmi M, Mellace M and Saidi RF:
Utilization of Treg Cells in Solid Organ Transplantation. Front
Immunol. 13:7468892022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kessel A, Haj T, Peri R, Snir A, Melamed
D, Sabo E and Toubi E: Human CD19(+)CD25(high) B regulatory cells
suppress proliferation of CD4(+) T cells and enhance Foxp3 and
CTLA-4 expression in T-regulatory cells. Autoimmun Rev. 11:670–677.
2012. View Article : Google Scholar
|
|
18
|
Lee KM, Stott RT, Zhao G, SooHoo J, Xiong
W, Lian MM, Fitzgerald L, Shi S, Akrawi E, Lei J, et al:
TGF-β-producing regulatory B cells induce regulatory T cells and
promote transplantation tolerance. Eur J Immunol. 44:1728–1736.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng S, Moore DJ, Huang X, Lian MM,
Mohiuddin M, Velededeoglu E, Lee MK IV, Sonawane S, Kim J, Wang J,
et al: Cutting edge: Transplant tolerance induced by anti-CD45RB
requires B lymphocytes. J Immunol. 178:6028–6032. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Singh A, Carson WF IV, Secor ER Jr,
Guernsey LA, Flavell RA, Clark RB, Thrall RS and Schramm CM:
Regulatory role of B cells in a murine model of allergic airway
disease. J Immunol. 180:7318–7326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao G, Moore DJ, Lee KM, Kim JI, Duff PE,
O'Connor MR, Hirohashi T, Lei J, Yang M, Markmann JF and Deng S: An
unexpected counter-regulatory role of IL-10 in
B-lymphocyte-mediated transplantation tolerance. Am J Transplant.
10:796–801. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lal G, Nakayama Y, Sethi A, Singh AK,
Burrell BE, Kulkarni N, Brinkman CC, Iwami D, Zhang T and Bromberg
JS: Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is
Required for Costimulatory Blockade-Induced Transplantation
Tolerance. Transplantation. 99:1817–1828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fillatreau S, Gray D and Anderton SM: Not
always the bad guys: B cells as regulators of autoimmune pathology.
Nat Rev Immunol. 8:391–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anderton SM and Fillatreau S: Activated B
cells in autoimmune diseases: the case for a regulatory role. Nat
Clin Pract Rheumatol. 4:657–666. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lanzavecchia A and Sallusto F: Toll-like
receptors and innate immunity in B-cell activation and antibody
responses. Curr Opin Immunol. 19:268–274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zindel J and Kubes P: DAMPs, PAMPs, and
LAMPs in immunity and sterile inflammation. Annu Rev Pathol.
15:493–518. 2020. View Article : Google Scholar
|
|
27
|
Romani L: Immunity to fungal infections.
Nat Rev Immunol. 11:275–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kumar V and Sharma A: Innate immunity in
sepsis pathogenesis and its modulation: New immunomodulatory
targets revealed. J Chemother. 20:672–683. 2008. View Article : Google Scholar
|
|
29
|
Iwasaki A and Medzhitov R: Regulation of
adaptive immunity by the innate immune system. Science.
327:291–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sîrbulescu RF, Mamidi A, Chan SY, Jin G,
Boukhali M, Sobell D, Ilieş I, Chung JY, Haas W, Whalen MJ, et al:
B cells support the repair of injured tissues by adopting
MyD88-dependent regulatory functions and phenotype. FASEB J.
35:e220192021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu Y, Wu K, Han S, Ding S, Lu G, Lin Z,
Zhang Y, Xiao W, Gong W, Ding Y and Deng B: Astilbin combined with
lipopolysaccharide induces IL-10-producing regulatory B cells via
the STAT3 signalling pathway. Biomed Pharmacother. 129:1104502020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lampropoulou V, Hoehlig K, Roch T, Neves
P, Calderón Gómez E, Sweenie CH, Hao Y, Freitas AA, Steinhoff U,
Anderton SM and Fillatreau S: TLR-activated B cells suppress T
cell-mediated autoimmunity. J Immunol. 180:4763–4773. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu BS, Cao Y, Huizinga TW, Hafler DA and
Toes RE: TLR-mediated STAT3 and ERK activation controls IL-10
secretion by human B cells. Eur J Immunol. 44:2121–2129. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: update on
Toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pasare C and Medzhitov R: Control of
B-cell responses by Toll-like receptors. Nature. 438:364–368. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoshizaki A, Miyagaki T, DiLillo DJ,
Matsushita T, Horikawa M, Kountikov EI, Spolski R, Poe JC, Leonard
WJ and Tedder TF: Regulatory B cells control T-cell autoimmunity
through IL-21-dependent cognate interactions. Nature. 491:264–268.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Barr TA, Brown S, Ryan G, Zhao J and Gray
D: TLR-mediated stimulation of APC: Distinct cytokine responses of
B cells and dendritic cells. Eur J Immunol. 37:3040–3053. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hao Y, O'Neill P, Naradikian MS, Scholz JL
and Cancro MP: A B-cell subset uniquely responsive to innate
stimuli accumulates in aged mice. Blood. 118:1294–1304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takeda K and Akira S: TLR signaling
pathways. Semin Immunol. 16:3–9. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tian F, Xian K, Yang B, Duan Q, Qian L and
Shi C: Deficiency in TLR4 impairs regulatory B cells production
induced by Schistosome soluble egg antigen. Mol Biochem Parasitol.
253:1115322023. View Article : Google Scholar
|
|
41
|
Oladipupo FO, Yu CR, Olumuyide E,
Jittaysothorn Y, Choi JK and Egwuagu CE: STAT3 deficiency in B
cells exacerbates uveitis by promoting expansion of pathogenic
lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.
Sci Rep. 10:161882020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shankar S, Stolp J, Juvet SC, Beckett J,
Macklin PS, Issa F, Hester J and Wood KJ: Ex vivo-expanded human
CD19+TIM-1+ regulatory B cells suppress immune responses in vivo
and are dependent upon the TIM-1/STAT3 axis. Nat Commun.
13:31212022. View Article : Google Scholar :
|
|
43
|
Bauer S, Kirschning CJ, Häcker H, Redecke
V, Hausmann S, Akira S, Wagner H and Lipford GB: Human TLR9 confers
responsiveness to bacterial DNA via species-specific CpG motif
recognition. Proc Natl Acad Sci USA. 98:9237–9242. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ohto U, Shibata T, Tanji H, Ishida H,
Krayukhina E, Uchiyama S, Miyake K and Shimizu T: Structural basis
of CpG and inhibitory DNA recognition by Toll-like receptor 9.
Nature. 520:702–705. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Akkaya M, Akkaya B, Kim AS, Miozzo P, Sohn
H, Pena M, Roesler AS, Theall BP, Henke T, Kabat J, et al:
Toll-like receptor 9 antagonizes antibody affinity maturation. Nat
Immunol. 19:255–266. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Alaqla A, Hu Y, Huang S, Ruiz S, Kawai T
and Han X: TLR9 signaling is required for the porphyromonas
gingivalis-induced activation of IL-10-expressing B cells. Int J
Mol Sci. 24:66932023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ohto U and Shimizu T: Structural aspects
of nucleic acid-sensing Toll-like receptors. Biophys Rev. 8:33–43.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hu Q, Li H, Wang L, Gu H and Fan C: DNA
Nanotechnology-Enabled drug delivery systems. Chem Rev.
119:6459–6506. 2019. View Article : Google Scholar
|
|
49
|
Mutwiri G, van Drunen Littel-van den Hurk
S and Babiuk LA: Approaches to enhancing immune responses
stimulated by CpG oligodeoxynucleotides. Adv Drug Deliv Rev.
61:226–232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kawai T and Akira S: Signaling to
NF-kappaB by Toll-like receptors. Trends Mol Med. 13:460–469. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Uematsu S, Sato S, Yamamoto M, Hirotani T,
Kato H, Takeshita F, Matsuda M, Coban C, Ishii KJ, Kawai T, et al:
Interleukin-1 receptor-associated kinase-1 plays an essential role
for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha}
induction. J Exp Med. 201:915–923. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Walsh MC, Lee J and Choi Y: Tumor necrosis
factor receptor-associated factor 6 (TRAF6) regulation of
development, function, and homeostasis of the immune system.
Immunol Rev. 266:72–92. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
O'Neill LA and Bowie AG: The family of
five: TIR-domain-containing adaptors in Toll-like receptor
signalling. Nat Rev Immunol. 7:353–364. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji
J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O and Akira S:
Essential function for the kinase TAK1 in innate and adaptive
immune responses. Nat Immunol. 6:1087–1095. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang M, Sun L, Wang S, Ko KH, Xu H, Zheng
BJ, Cao X and Lu L: Novel function of B cell-activating factor in
the induction of IL-10-producing regulatory B cells. J Immunol.
184:3321–3325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Huang X and Yang Y: Targeting the
TLR9-MyD88 pathway in the regulation of adaptive immune responses.
Expert Opin Ther Targets. 14:787–796. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Honke N, Lowin T, Opgenoorth B, Shaabani
N, Lautwein A, Teijaro JR, Schneider M and Pongratz G: Endogenously
produced catecholamines improve the regulatory function of
TLR9-activated B cells. PLoS Biol. 20:e30015132022. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Pongratz G, Melzer M and Straub RH: The
sympathetic nervous system stimulates anti-inflammatory B cells in
collagen-type II-induced arthritis. Ann Rheum Dis. 71:432–439.
2012. View Article : Google Scholar
|
|
59
|
Darnell JE Jr: STATs and gene regulation.
Science. 277:1630–1635. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Levy DE and Darnell JE Jr: Stats:
Transcriptional control and biological impact. Nat Rev Mol Cell
Biol. 3:651–662. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
61
|
Bromberg J: Stat proteins and oncogenesis.
J Clin Invest. 109:1139–1142. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Bromberg JF, Wrzeszczynska MH, Devgan G,
Zhao Y, Pestell RG, Albanese C and Darnell JE Jr: Stat3 as an
oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang YH, Tsai DY, Ko YA, Yang TT, Lin IY,
Hung KH and Lin KI: Blimp-1 Contributes to the Development and
Function of Regulatory B Cells. Front Immunol. 10:19092019.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Diehl SA, Schmidlin H, Nagasawa M, van
Haren SD, Kwakkenbos MJ, Yasuda E, Beaumont T, Scheeren FA and
Spits H: STAT3-mediated up-regulation of BLIMP1 Is coordinated with
BCL6 down-regulation to control human plasma cell differentiation.
J Immunol. 180:4805–4815. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Michée-Cospolite M, Boudigou M, Grasseau
A, Simon Q, Mignen O, Pers JO, Cornec D, Le Pottier L and Hillion
S: Molecular Mechanisms Driving IL-10- Producing B Cells Functions:
STAT3 and c-MAF as Underestimated Central Key Regulators? Front
Immunol. 13:8188142022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Jin G, Hamaguchi Y, Matsushita T, Hasegawa
M, Le Huu D, Ishiura N, Naka K, Hirao A, Takehara K and Fujimoto M:
B-cell linker protein expression contributes to controlling
allergic and autoimmune diseases by mediating IL-10 production in
regulatory B cells. J Allergy Clin Immunol. 131:1674–1682. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhou M, Wen Z, Cheng F, Ma J, Li W, Ren H,
Sheng Y, Dong H, Lu L, Hu HM and Wang LX: Tumor-released
autophagosomes induce IL-10-producing B cells with suppressive
activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathway.
Oncoimmunology. 5:e11804852016. View Article : Google Scholar
|
|
68
|
Wang K, Tao L, Su J, Zhang Y, Zou B, Wang
Y, Zou M, Chen N, Lei L and Li X: TLR4 supports the expansion of
FasL + CD5 + CD1d hi regulatory B cells, which decreases in contact
hypersensitivity. Mol Immunol. 87:188–199. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lee MB, Lee JH, Hong SH, You JS, Nam ST,
Kim HW, Park YH, Lee D, Min KY, Park YM, et al: JQ1, a BET
inhibitor, controls TLR4-induced IL-10 production in regulatory B
cells by BRD4-NF-κB axis. BMB Rep. 50:640–646. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Pore D, Matsui K, Parameswaran N and Gupta
N: Cutting Edge: Ezrin Regulates Inflammation by Limiting B Cell
IL-10 Production. J Immunol. 196:558–562. 2016. View Article : Google Scholar
|
|
71
|
Mishima Y, Oka A, Liu B, Herzog JW, Eun
CS, Fan TJ, Bulik-Sullivan E, Carroll IM, Hansen JJ, Chen L, et al:
Microbiota maintain colonic homeostasis by activating
TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells. J
Clin Invest. 129:3702–3716. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lanzavecchia A: Antigen-specific
interaction between T and B cells. Nature. 314:537–539. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Clark MR, Campbell KS, Kazlauskas A,
Johnson SA, Hertz M, Potter TA, Pleiman C and Cambier JC: The B
cell antigen receptor complex: Association of Ig-alpha and Ig-beta
with distinct cytoplasmic effectors. Science. 258:123–126. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Reth M: Antigen receptor tail clue.
Nature. 338:383–384. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Niiro H and Clark EA: Regulation of B-cell
fate by antigen-receptor signals. Nat Rev Immunol. 2:945–956. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Dal Porto JM, Gauld SB, Merrell KT, Mills
D, Pugh-Bernard AE and Cambier J: B cell antigen receptor signaling
101. Mol Immunol. 41:599–613. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Saijo K, Schmedt C, Su IH, Karasuyama H,
Lowell CA, Reth M, Adachi T, Patke A, Santana A and Tarakhovsky A:
Essential role of Src-family protein tyrosine kinases in NF-kappaB
activation during B cell development. Nat Immunol. 4:274–279. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Carter RH and Fearon DT: CD19: lowering
the threshold for antigen receptor stimulation of B lymphocytes.
Science. 256:105–107. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Baracho GV, Miletic AV, Omori SA, Cato MH
and Rickert RC: Emergence of the PI3-kinase pathway as a central
modulator of normal and aberrant B cell differentiation. Curr Opin
Immunol. 23:178–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Fujimoto M, Fujimoto Y, Poe JC, Jansen PJ,
Lowell CA, DeFranco AL and Tedder TF: CD19 regulates Src family
protein tyrosine kinase activation in B lymphocytes through
processive amplification. Immunity. 13:47–57. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Gold MR, Law DA and DeFranco AL:
Stimulation of protein tyrosine phosphorylation by the B-lymphocyte
antigen receptor. Nature. 345:810–813. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Fillatreau S, Sweenie CH, McGeachy MJ,
Gray D and Anderton SM: B cells regulate autoimmunity by provision
of IL-10. Nat Immunol. 3:944–950. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Yanaba K, Bouaziz JD, Matsushita T,
Tsubata T and Tedder TF: The development and function of regulatory
B cells expressing IL-10 (B10 cells) requires antigen receptor
diversity and TLR signals. J Immunol. 182:7459–7472. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Hussain S and Delovitch TL: Intravenous
transfusion of BCR-activated B cells protects NOD mice from type 1
diabetes in an IL-10-dependent manner. J Immunol. 179:7225–7232.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Adori M, Khoenkhoen S, Zhang J, Dopico XC
and Karlsson Hedestam GB: Enhanced B Cell Receptor Signaling
Partially Compensates for Impaired Toll-like Receptor 4 Responses
in LPS-Stimulated IκBNS-Deficient B Cells. Cells. 12:12292023.
View Article : Google Scholar
|
|
86
|
Tedder TF: B10 cells: A functionally
defined regulatory B cell subset. J Immunol. 194:1395–1401. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Parekh VV, Prasad DVR, Banerjee PP, Joshi
BN, Kumar A and Mishra GC: B cells activated by lipopolysaccharide,
but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T
cells: role of TGF-beta 1. J Immunol. 170:5897–5911. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hazeki K, Nigorikawa K and Hazeki O: Role
of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull.
30:1617–1723. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ruse M and Knaus UG: New players in
TLR-mediated innate immunity: PI3K and small Rho GTPases. Immunol
Res. 34:33–48. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Tuveson DA, Carter RH, Soltoff SP and
Fearon DT: CD19 of B cells as a surrogate kinase insert region to
bind phosphatidylinositol 3-kinase. Science. 260:986–989. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Ingham RJ, Holgado-Madruga M, Siu C, Wong
AJ and Gold MR: The Gab1 protein is a docking site for multiple
proteins involved in signaling by the B cell antigen receptor. J
Biol Chem. 273:30630–30637. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Okada T, Maeda A, Iwamatsu A, Gotoh K and
Kurosaki T: BCAP: The tyrosine kinase substrate that connects B
cell receptor to phosphoinositide 3-kinase activation. Immunity.
13:817–827. 2000. View Article : Google Scholar
|
|
93
|
Panchamoorthy G, Fukazawa T, Miyake S,
Soltoff S, Reedquist K, Druker B, Shoelson S, Cantley L and Band H:
p120cbl is a major substrate of tyrosine phosphorylation upon B
cell antigen receptor stimulation and interacts in vivo with Fyn
and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85
subunit of phosphatidylinositol 3-kinase. J Biol Chem.
271:3187–3194. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Gold MR: Intermediary signaling effectors
coupling the B-cell receptor to the nucleus. Curr Top Microbiol
Immunol. 245:77–134. 2000.
|
|
95
|
Marshall AJ, Niiro H, Yun TJ and Clark EA:
Regulation of B-cell activation and differentiation by the
phosphatidylinositol 3-kinase and phospholipase Cgamma pathway.
Immunol Rev. 176:30–46. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Lemmon MA and Ferguson KM:
Signal-dependent membrane targeting by pleckstrin homology (PH)
domains. Biochem J. 350 Pt 1(Pt 1): 1–18. 2000.PubMed/NCBI
|
|
97
|
Scheid MP and Woodgett JR: PKB/AKT:
Functional insights from genetic models. Nat Rev Mol Cell Biol.
2:760–768. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Cross DA, Alessi DR, Cohen P, Andjelkovich
M and Hemmings BA: Inhibition of glycogen synthase kinase-3 by
insulin mediated by protein kinase B. Nature. 378:785–789. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Li J, Gao J, Zhou H, Zhou J, Deng Z, Lu Y,
Rao J, Ji G, Gu J, Yang X, et al: Inhibition of glycogen synthase
kinase 3β increases the proportion and suppressive function of
CD19+CD24hiCD27+ breg cells. Front Immunol. 11:6032882020.
View Article : Google Scholar
|
|
100
|
Kaidanovich-Beilin O and Woodgett JR:
GSK-3: Functional insights from cell biology and animal models.
Front Mol Neurosci. 4:402011. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Maurer U, Preiss F, Brauns-Schubert P,
Schlicher L and Charvet C: GSK-3 - at the crossroads of cell death
and survival. J Cell Sci. 127(Pt 7): 1369–1378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Gold MR, Scheid MP, Santos L, Dang-Lawson
M, Roth RA, Matsuuchi L, Duronio V and Krebs DL: The B cell antigen
receptor activates the Akt (protein kinase B)/glycogen synthase
kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J
Immunol. 163:1894–1905. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Cheng H, Wang L, Yang B, Li D, Wang X, Liu
X, Tian N, Huang Q, Feng R, Wang Z, et al: Cutting edge: Inhibition
of glycogen synthase kinase 3 activity induces the generation and
enhanced suppressive function of human IL-10+ FOXP3+-induced
regulatory T Cells. J Immunol. 205:1497–1502. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Mielle J, Morel J, Elhmioui J, Combe B,
Macia L, Dardalhon V, Taylor N, Audo R and Daien C: Glutamine
promotes the generation of B10+ cells via the mTOR/GSK3 pathway.
Eur J Immunol. 52:418–430. 2022. View Article : Google Scholar
|
|
105
|
Chen Z and Wang JH: How the signaling
crosstalk of B cell receptor (BCR) and Co-receptors regulates
antibody class switch recombination: A new perspective of
checkpoints of BCR signaling. Front Immunol. 12:6634432021.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Tsubata T, Wu J and Honjo T: B-cell
apoptosis induced by antigen receptor crosslinking is blocked by a
T-cell signal through CD40. Nature. 364:645–648. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Xu J, Foy TM, Laman JD, Elliott EA, Dunn
JJ, Waldschmidt TJ, Elsemore J, Noelle RJ and Flavell RA: Mice
deficient for the CD40 ligand. Immunity. 1:423–431. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Wang SP, Iwata S, Nakayamada S, Niiro H,
Jabbarzadeh-Tabrizi S, Kondo M, Kubo S, Yoshikawa M and Tanaka Y:
Amplification of IL-21 signalling pathway through Bruton's tyrosine
kinase in human B cell activation. Rheumatology (Oxford).
54:1488–1497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Bishop GA and Hostager BS: Signaling by
CD40 and its mimics in B cell activation. Immunol Res. 24:97–109.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Poe JC, Smith SH, Haas KM, Yanaba K,
Tsubata T, Matsushita T and Tedder TF: Amplified B lymphocyte CD40
signaling drives regulatory B10 cell expansion in mice. PLoS One.
6:e224642011. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Chen C, Ma J, Pi C, Huang W, Zhang T, Fu
C, Liu W and Yang YG: PPARδ inhibition blocks the induction and
function of tumor-induced IL-10+ regulatory B cells and enhances
cancer immunotherapy. Cell Discov. 9:542023. View Article : Google Scholar
|
|
112
|
Durand J, Huchet V, Merieau E, Usal C,
Chesneau M, Remy S, Heslan M, Anegon I, Cuturi MC, Brouard S and
Chiffoleau E: Regulatory B cells with a partial defect in CD40
signaling and overexpressing granzyme B transfer allograft
tolerance in rodents. J Immunol. 195:5035–5044. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Jansen K, Cevhertas L, Ma S, Satitsuksanoa
P, Akdis M and Van De Veen W: Regulatory B cells, A to Z. Allergy.
76:2699–2715. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Fu Q, Lee KM, Huai G, Deng K, Agarwal D,
Rickert CG, Feeney N, Matheson R, Yang H, LeGuern C, et al:
Properties of regulatory B cells regulating B cell targets. Am J
Transplant. 21:3847–3857. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Matsumoto M, Baba A, Yokota T, Nishikawa
H, Ohkawa Y, Kayama H, Kallies A, Nutt SL, Sakaguchi S, Takeda K,
et al: Interleukin-10-producing plasmablasts exert regulatory
function in autoimmune inflammation. Immunity. 41:1040–1051. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Baba Y, Matsumoto M and Kurosaki T:
Signals controlling the development and activity of regulatory
B-lineage cells. Int Immunol. 27:487–493. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Bankó Z, Pozsgay J, Szili D, Tóth M, Gáti
T, Nagy G, Rojkovich B and Sármay G: Induction and differentiation
of IL-10-producing regulatory B cells from healthy blood donors and
rheumatoid arthritis patients. J Immunol. 198:1512–1520. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Inaba A, Tuong ZK, Zhao TX, Stewart AP,
Mathews R, Truman L, Sriranjan R, Kennet J, Saeb-Parsy K, Wicker L,
et al: Low-dose IL-2 enhances the generation of IL-10-producing
immunoregulatory B cells. Nat Commun. 14:20712023. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Rosser EC, Oleinika K, Tonon S, Doyle R,
Bosma A, Carter NA, Harris KA, Jones SA, Klein N and Mauri C:
Regulatory B cells are induced by gut microbiota-driven
interleukin-1β and interleukin-6 production. Nat Med. 20:1334–1339.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Liu X, Huang H, Gao H, Wu X, Zhang W, Yu B
and Dou X: Regulatory B cells induced by ultraviolet B through
toll-like receptor 4 signalling contribute to the suppression of
contact hypersensitivity responses in mice. Contact Dermatitis.
78:117–130. 2018. View Article : Google Scholar
|
|
121
|
Poe JC, Haas KM, Uchida J, Lee Y, Fujimoto
M and Tedder TF: Severely impaired B lymphocyte proliferation,
survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase
pathway resulting from CD22 deficiency on the C57BL/6 genetic
background. J Immunol. 172:2100–2110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Iwata Y, Matsushita T, Horikawa M, Dilillo
DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM,
Williams AD, et al: Characterization of a rare IL-10-competent
B-cell subset in humans that parallels mouse regulatory B10 cells.
Blood. 117:530–541. 2011. View Article : Google Scholar :
|
|
123
|
Li X, Zhong H, Bao W, Boulad N,
Evangelista J, Haider MA, Bussel J and Yazdanbakhsh K: Defective
regulatory B-cell compartment in patients with immune
thrombocytopenia. Blood. 120:3318–3325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Khoder A, Sarvaria A, Alsuliman A, Chew C,
Sekine T, Cooper N, Mielke S, de Lavallade H, Muftuoglu M,
Fernandez Curbelo I, et al: Regulatory B cells are enriched within
the IgM memory and transitional subsets in healthy donors but are
deficient in chronic GVHD. Blood. 124:2034–2045. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Lee KM, Fu Q, Huai G, Deng K, Lei J,
Kojima L, Agarwal D, van Galen P, Kimura S, Tanimine N, et al:
Suppression of allograft rejection by regulatory B cells induced
via TLR signaling. JCI Insight. 7:e1522132022. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Veh J, Mangold C, Felsen A, Ludwig C,
Gerstner L, Reinhardt P, Schrezenmeier H, Fabricius D and
Jahrsdörfer B: Phorbol-12-myristate-13-acetate is a potent enhancer
of B cells with a granzyme B+ regulatory phenotype. Front Immunol.
14:11948802023. View Article : Google Scholar :
|
|
127
|
Han Y, Yu C, Yu Y and Bi L: CD25+ B cells
produced IL-35 and alleviated local inflammation during
experimental periodontitis. Oral Dis. 28:2248–2257. 2022.
View Article : Google Scholar
|
|
128
|
Zeng R, Spolski R, Casas E, Zhu W, Levy DE
and Leonard WJ: The molecular basis of IL-21-mediated
proliferation. Blood. 109:4135–4142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Zheremyan EA, Ustiugova AS, Uvarova AN,
Karamushka NM, Stasevich EM, Gogoleva VS, Bogolyubova AV, Mitkin
NA, Kuprash DV and Korneev KV: Differentially activated B cells
develop regulatory phenotype and show varying immunosuppressive
features: A comparative study. Front Immunol. 14:11784452023.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Chesneau M, Mai HL, Danger R, Le Bot S,
Nguyen TV, Bernard J, Poullaouec C, Guerrif P, Conchon S, Giral M,
et al: Efficient expansion of human granzyme B-expressing B cells
with potent regulatory properties. J Immunol. 205:2391–2401. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Thompson R and Cao X: Reassessing granzyme
B: Unveiling perforin-independent versatility in immune responses
and therapeutic potentials. Front Immunol. 15:13925352024.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Menon M, Blair PA, Isenberg DA and Mauri
C: A regulatory feedback between plasmacytoid dendritic cells and
regulatory B cells is aberrant in systemic lupus erythematosus.
Immunity. 44:683–697. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Mohib K, Rothstein DM and Ding Q:
Characterization and activity of TIM-1 and IL-10-reporter
expressing regulatory B cells. Methods Mol Biol. 2270:179–202.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Carvajal Alegria G, Cornec D, Saraux A,
Devauchelle-Pensec V, Jamin C, Hillion S and Pochard P: Abatacept
promotes regulatory B cell functions, enhancing their ability to
reduce the Th1 response in rheumatoid arthritis patients through
the production of IL-10 and TGF-β. J Immunol. 207:470–482. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Song J, Xiao L, Du G, Gao Y, Chen W, Yang
S, Fan W and Shi B: The role of regulatory B cells (Bregs) in the
Tregs-amplifying effect of Sirolimus. Int Immunopharmacol.
38:90–96. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Wu M, Yu S, Chen Y, Meng W, Chen H, He J,
Shen J and Lin X: Acteoside promotes B cell-derived IL-10
production and ameliorates autoimmunity. J Leukoc Biol.
112:875–885. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Mielle J, Audo R, Hahne M, Macia L, Combe
B, Morel J and Daien C: IL-10 producing B cells ability to induce
regulatory T cells is maintained in rheumatoid arthritis. Front
Immunol. 9:9612018. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Goretzki A, Lin YJ, Meier C, Dorn B,
Wolfheimer S, Jamin A, Schott M, Wangorsch A, Vieths S, Jakob T, et
al: Stimulation of naïve B cells with a fusion protein consisting
of FlaA and Bet v 1 induces regulatory B cells ex vivo. Allergy.
78:663–681. 2023. View Article : Google Scholar
|
|
139
|
Giacomini E, Rizzo F, Etna MP, Cruciani M,
Mechelli R, Buscarinu MC, Pica F, D'Agostini C, Salvetti M, Coccia
EM and Severa M: Thymosin-α1 expands deficient IL-10-producing
regulatory B cell subsets in relapsing-remitting multiple sclerosis
patients. Mult Scler. 24:127–139. 2018. View Article : Google Scholar
|
|
140
|
Li W, Wang D, Yue R, Chen X, Liu A, Xu H,
Teng P, Wang Z, Zou Y, Xu X, et al: Gut microbes enlarged the
protective effect of transplanted regulatory B cells on rejection
of cardiac allografts. J Heart Lung Transplant. 40:1502–1516. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Liao W, Xiao H, He J, Huang L, Liao Y, Qin
J, Yang Q, Ma F and Li S: B-Cell-activating factor contributes to
elevation of the content of regulatory B cells in neonatal sepsis.
Bull Exp Biol Med. 175:72–77. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Saulep-Easton D, Vincent FB, Quah PS, Wei
A, Ting SB, Croce CM, Tam C and Mackay F: The BAFF receptor TACI
controls IL-10 production by regulatory B cells and CLL B cells.
Leukemia. 30:163–172. 2016. View Article : Google Scholar
|
|
143
|
Hua C, Audo R, Yeremenko N, Baeten D,
Hahne M, Combe B, Morel J and Daïen C: A proliferation inducing
ligand (APRIL) promotes IL-10 production and regulatory functions
of human B cells. J Autoimmun. 73:64–72. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Fehres CM, van Uden NO, Yeremenko NG,
Fernandez L, Franco Salinas G, van Duivenvoorde LM, Huard B, Morel
J, Spits H, Hahne M and Baeten DLP: APRIL induces a novel subset of
IgA+ regulatory B cells that suppress inflammation via expression
of IL-10 and PD-L1. Front Immunol. 10:13682019. View Article : Google Scholar :
|
|
145
|
Planelles L, Carvalho-Pinto CE, Hardenberg
G, Smaniotto S, Savino W, Gómez-Caro R, Alvarez-Mon M, de Jong J,
Eldering E, Martínez-A C, et al: APRIL promotes B-1 cell-associated
neoplasm. Cancer Cell. 6:399–408. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Zhang Y, Li J, Zhou N, Zhang Y, Wu M, Xu
J, Shen C, An X, Shen G, Yang M, et al: The unknown aspect of BAFF:
Inducing IL-35 production by a CD5+CD1dhiFcγRIIbhi regulatory
B-cell subset in lupus. J Invest Dermatol. 137:2532–2543. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
den Hartog G, van Osch TLJ, Vos M, Meijer
B, Savelkoul HFJ, van Neerven RJJ and Brugman S: BAFF augments IgA2
and IL-10 production by TLR7/8 stimulated total peripheral blood B
cells. Eur J Immunol. 48:283–292. 2018. View Article : Google Scholar
|
|
148
|
Komlósi ZI, Kovács N, van de Veen W,
Kirsch AI, Fahrner HB, Wawrzyniak M, Rebane A, Stanic B, Palomares
O, Rückert B, et al: Human CD40 ligand-expressing type 3 innate
lymphoid cells induce IL-10-producing immature transitional
regulatory B cells. J Allergy Clin Immunol. 142:178–194.e11. 2018.
View Article : Google Scholar
|
|
149
|
Mu Y, Xu W, Liu J, Wang Y, Chen J and Zhou
Q: Mesenchymal stem cells moderate experimental autoimmune uveitis
by dynamic regulating Th17 and Breg cells response. J Tissue Eng
Regen Med. 16:26–35. 2022. View Article : Google Scholar
|
|
150
|
Franquesa M, Mensah FK, Huizinga R, Strini
T, Boon L, Lombardo E, DelaRosa O, Laman JD, Grinyó JM, Weimar W,
et al: Human adipose tissue-derived mesenchymal stem cells abrogate
plasmablast formation and induce regulatory B cells independently
of T helper cells. Stem Cells. 33:880–891. 2015. View Article : Google Scholar
|
|
151
|
Luk F, de Witte SF, Korevaar SS,
Roemeling-van Rhijn M, Franquesa M, Strini T, van den Engel S,
Gargesha M, Roy D, Dor FJ, et al: Inactivated mesenchymal stem
cells maintain immunomodulatory capacity. Stem Cells Dev.
25:1342–1354. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Ye L, Zhang Q, Cheng Y, Chen X, Wang G,
Shi M, Zhang T, Cao Y, Pan H, Zhang L, et al: Tumor-derived
exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by
promoting TIM-1+ regulatory B cell expansion. J Immunother Cancer.
6:1452018. View Article : Google Scholar :
|
|
153
|
Blache U, Tretbar S, Koehl U, Mougiakakos
D and Fricke S: CAR T cells for treating autoimmune diseases. RMD
Open. 9:e0029072023. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Cremoni M, Massa F and Sicard A:
Overcoming barriers to widespread use of CAR-Treg therapy in organ
transplant recipients. HLA. 99:565–572. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Calderón-Gómez E and Fillatreau S:
Utilization of a lentiviral system for the generation of B cells
with regulatory properties. Methods Mol Biol. 1190:105–113. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Alonso-Guallart P, Llore N, Lopes E,
Kofman SB, Ho SH, Stern J, Pierre G, Bruestle K, Tang Q, Sykes M
and Griesemer A: CD40L-stimulated B cells for ex-vivo expansion of
polyspecific non-human primate regulatory T cells for translational
studies. Clin Exp Immunol. 203:480–492. 2021. View Article : Google Scholar
|
|
157
|
Abreu TR, Fonseca NA, Gonçalves N and
Moreira JN: Current challenges and emerging opportunities of CAR-T
cell therapies. J Control Release. 319:246–261. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Miliotou AN and Papadopoulou LC: CAR
T-cell Therapy: A New Era in Cancer Immunotherapy. Curr Pharm
Biotechnol. 19:5–18. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Wilhelm A, Chambers D, Müller F, Bozec A,
Grieshaber-Bouyer R, Winkler T, Mougiakakos D, Mackensen A, Schett
G and Krönke G: Selective CAR T cell-mediated B cell depletion
suppresses IFN signature in SLE. JCI Insight. 9:e1794332024.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Wagner JC, Ronin E, Ho P, Peng Y and Tang
Q: Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic
heart allograft survival. Am J Transplant. 22:2237–2245. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Mansourabadi AH, Mohamed Khosroshahi L,
Noorbakhsh F and Amirzargar A: Cell therapy in transplantation: A
comprehensive review of the current applications of cell therapy in
transplant patients with the focus on Tregs, CAR Tregs, and
Mesenchymal stem cells. Int Immunopharmacol. 97:1076692021.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Montgomery RA, Tatapudi VS, Leffell MS and
Zachary AA: HLA in transplantation. Nat Rev Nephrol. 14:558–570.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Bodis G, Toth V and Schwarting A: Role of
human leukocyte antigens (HLA) in autoimmune diseases. Rheumatol
Ther. 5:5–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Boardman DA, Philippeos C, Fruhwirth GO,
Ibrahim MA, Hannen RF, Cooper D, Marelli-Berg FM, Watt FM, Lechler
RI, Maher J, et al: Expression of a chimeric antigen receptor
specific for donor HLA class I enhances the potency of human
regulatory T cells in preventing human skin transplant rejection.
Am J Transplant. 17:931–943. 2017. View Article : Google Scholar
|
|
165
|
González-Galarza FF, Takeshita LY, Santos
EJ, Kempson F, Maia MH, da Silva AL, Teles e Silva AL, Ghattaoraya
GS, Alfirevic A, Jones AR and Middleton D: Allele frequency net
2015 update: new features for HLA epitopes, KIR and disease and HLA
adverse drug reaction associations. Nucleic Acids Res. 43(Database
Issue): D784–D788. 2015. View Article : Google Scholar :
|
|
166
|
Ajith A, Mamouni K, Musa A, Horuzsko DD,
Gani I, Mulloy LL and Horuzsko A: IL-10-producing memory B
regulatory cells as a novel target for HLA-G to prolong human
kidney allograft survival. Hum Immunol. 84:366–373. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Bottomley MJ, Brook MO, Shankar S, Hester
J and Issa F: Towards regulatory cellular therapies in solid organ
transplantation. Trends Immunol. 43:8–21. 2022. View Article : Google Scholar
|
|
168
|
McNee A, Kannan A, Jull P and Shankar S:
Expanding human breg for cellular therapy in transplantation: Time
for translation. Transplantation. Oct 23–2024.Epub ahead of print.
View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Geissler EK and Hutchinson JA: Cell
therapy as a strategy to minimize maintenance immunosuppression in
solid organ transplant recipients. Curr Opin Organ Transplant.
18:408–415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Chu Z, Zou W, Xu Y, Sun Q and Zhao Y: The
regulatory roles of B cell subsets in transplantation. Expert Rev
Clin Immunol. 14:115–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Mohib K, Cherukuri A and Rothstein DM:
Regulatory B cells and transplantation: Almost prime time? Curr
Opin Organ Transplant. 23:524–532. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Chesneau M, Michel L, Degauque N and
Brouard S: Regulatory B cells and tolerance in transplantation:
From animal models to human. Front Immunol. 4:4972013. View Article : Google Scholar
|
|
173
|
Silva HM, Takenaka MC, Moraes-Vieira PM,
Monteiro SM, Hernandez MO, Chaara W, Six A, Agena F, Sesterheim P,
Barbé-Tuana FM, et al: Preserving the B-cell compartment favors
operational tolerance in human renal transplantation. Mol Med.
18:733–743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Clatworthy MR, Watson CJ, Plotnek G,
Bardsley V, Chaudhry AN, Bradley JA and Smith KG: B-cell-depleting
induction therapy and acute cellular rejection. N Engl J Med.
360:2683–2685. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Veh J, Ludwig C, Schrezenmeier H and
Jahrsdörfer B: Regulatory B cells-immunopathological and prognostic
potential in humans. Cells. 13:3572024. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Le Huu D, Matsushita T, Jin G, Hamaguchi
Y, Hasegawa M, Takehara K, Tedder TF and Fujimoto M: Donor-derived
regulatory B cells are important for suppression of murine
sclerodermatous chronic graft-versus-host disease. Blood.
121:3274–3283. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Fang T, Koo TY, Lee JG, Jang JY, Xu Y,
Hwang JH, Park S, Yan JJ, Ryu JH, Ryu YM, et al: Anti-CD45RB
antibody therapy attenuates renal ischemia-reperfusion injury by
inducing regulatory B cells. J Am Soc Nephrol. 30:1870–1885. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Matsushita T: Regulatory and effector B
cells: Friends or foes? J Dermatol Sci. 93:2–7. 2019. View Article : Google Scholar
|
|
179
|
Zhao H, Feng R, Peng A, Li G and Zhou L:
The expanding family of noncanonical regulatory cell subsets. J
Leukoc Biol. 106:369–383. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Natarajan P, Singh A, McNamara JT, Secor
ER, Guernsey LA, Thrall RS and Schramm CM: Regulatory B cells from
hilar lymph nodes of tolerant mice in a murine model of allergic
airway disease are CD5+, express TGF-β, and co-localize with
CD4+Foxp3+ T cells. Mucosal Immunol. 5:691–701. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Khalil MI, Gurski CJ, Dittel LJ, Neu SD
and Dittel BN: Discovery and Function of B-Cell IgD Low (BDL) B
Cells in Immune Tolerance. J Mol Biol. 433:1665842021. View Article : Google Scholar
|
|
182
|
Agbogan VA, Gastineau P, Tejerina E,
Karray S and Zavala F: CpG-Activated regulatory B-cell progenitors
alleviate murine graft-versus-host-disease. Front Immunol.
13:7905642022. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Lal G, Kulkarni N, Nakayama Y, Singh AK,
Sethi A, Burrell BE, Brinkman CC, Iwami D, Zhang T, Hehlgans T and
Bromberg JS: IL-10 from marginal zone precursor B cells controls
the differentiation of Th17, Tfh and Tfr cells in transplantation
tolerance. Immunol Lett. 170:52–63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Bao Y and Xiu DR: Adaptive transfer of B10
cells: A novel therapy for chronic rejection after solid organ
transplantation. Med Hypotheses. 81:101–103. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Gorczynski RM, Farrokhi K, Gorczynski C,
Sadozai H, Zhu F and Khatri I: Importance of B cells to development
of regulatory T cells and prolongation of tissue allograft survival
in recipients receiving autologous bone marrow transplantation.
Immunology. 154:465–475. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Lindner S, Dahlke K, Sontheimer K, Hagn M,
Kaltenmeier C, Barth TF, Beyer T, Reister F, Fabricius D, Lotfi R,
et al: Interleukin 21-induced granzyme B-expressing B cells
infiltrate tumors and regulate T cells. Cancer Res. 73:2468–2479.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Horikawa M, Weimer ET, DiLillo DJ, Venturi
GM, Spolski R, Leonard WJ, Heise MT and Tedder TF: Regulatory B
cell (B10 Cell) expansion during Listeria infection governs innate
and cellular immune responses in mice. J Immunol. 190:1158–1168.
2013. View Article : Google Scholar : PubMed/NCBI
|
